Literature DB >> 4052642

Comment on 'Long-term tamoxifen adjuvant therapy in node positive breast cancer'.

A U Buzdar, G N Hortobagyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4052642     DOI： 10.1007/BF02235747

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  3 in total

1.  Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.

Authors:  D C Tormey; S G Taylor; R Gray; J E Olson
Journal:  Recent Results Cancer Res       Date:  1984

2.  Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.

Authors:  S G Taylor; L A Kalish; J E Olson; F Cummings; J M Bennett; G Falkson; D C Tormey; P P Carbone
Journal:  J Clin Oncol       Date:  1985-02       Impact factor: 44.544

3.  Long-term tamoxifen adjuvant therapy in node-positive breast cancer: a metabolic and pilot clinical study.

Authors:  D C Tormey; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.